Svp Non-Clinical Development
CurrentBuilding a Non-Clinical Development group to support development of a broad portfolio of incretin therapeutics.
Dec 2024 - Present
AeroLeads people directory · profile
Ian Pyrah Email & Phone Number
SVP Non-Clinical Development
at
Kailera Therapeutics
1 work email found
@seagen.com
1 phone found area 805
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
SVP Non-Clinical Development
Location
Greater Seattle Area, United States
Who is Ian Pyrah? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Ian Pyrah is listed as SVP Non-Clinical Development at Kailera Therapeutics, based in Greater Seattle Area, United States. AeroLeads shows a work email signal at seagen.com, phone signal with area code 805, and a matched LinkedIn profile for Ian Pyrah.
Ian Pyrah previously worked as SVP Translational Sciences at Immunome, Inc. and Chief Scientific Officer at Stealth Biotech Startup. Ian Pyrah holds Emba, Business Administration And Management, General from Ucla Anderson School Of Management.
Company email context
Email format at Kailera Therapeutics
This section adds company-level context without repeating Ian Pyrah's masked contact details.
{first_initial}{last}@seagen.com
86% confidence
AeroLeads found 1 current-domain work email signal for Ian Pyrah. Compare company email patterns before reaching out.
Profile bio
About Ian Pyrah
International Biopharma Business and Scientific Leader with over 20 years experience in top tier companies. Experienced with proven success across diverse therapeutic areas and all stages of drug discovery and development from target validation, animal model interpretation, biomarker development, IND submission, NDA/BLA submission, FDA advisory committee sponsor presenter, through post marketing assessment. International scientific thought leader within the toxicology community and regulatory authorities. Strong track record of recruiting and developing top talent. Trained and experienced in broad business skills, successfully initiating and leading cross-functional teams to deliver multimillion dollar savings and improved business efficiency. Balanced individual with strong ethics and community involvement.
Listed skills include Drug Discovery, Toxicology, Pathology, Drug Development, and 40 others.
Current workplace
Ian Pyrah's current company
Company context helps verify the profile and gives searchers a useful next step.
10 roles · 28 years
Ian Pyrah work experience
A career timeline built from the work history available for this profile.
Svp Translational Sciences
Built a Translational Sciences team from the ground up to support a portfolio of Antibody Drug Conjugates and Radioligand Therapies. Review and assessment of multiple in license opportunities. Support outbound business development.
Mar 2024 - Dec 2024
Chief Scientific Officer
Stealth Biotech Startup
Oct 2023 - Mar 2024
Chief Development Officer
Stealth Biotech Startup
Responsible for all Research and Development activities including scientific oversight of basic research, development and implementation of biomarkers, review of non-clinical safety, and design, conduct and analysis of FIH studies
Mar 2021 - Oct 2023
Senior Vice President Translational Sciences
Mar 2020 - Mar 2021
Vice President Translational Sciences
Leading Translational Sciences which includes non-clinical sciences, in vivo research, experimental pharmacology, clinical pharmacology, bioinformatics and biomarker development.
Oct 2017 - Mar 2020
Vice President Non-Clinical Sciences
Jun 2016 - Oct 2017
Preclinical Executive Director
Leadership accountability for delivery of the late stage portfolio including direct accountability for toxicology project input and responsibility for cross functional integration of all data for recent successful submissions including Prolia, Xgeva, Blincyto, Corlanor, Repatha, Neupogen/Neulasta, Imlygic. Successful in recruiting, developing, and mentoring scientific and operational staff including a wide range of grade levels.Leadership accountability for cross functional supply chain and logistic project with annual budget in excess of $140M with direct accountability to R&D SVPs which required forming and leading a team of senior executives from operations, finance, global sourcing, and R&D to successfully develop a vision and drive strategy against that vision. Successful in achieving multi-million dollar annual savings and major service improvement.Leadership accountability for major change initiative “Amgen Full Potential” in discovery research and translational sciences – working cross functionally to develop a flexible and responsive business model and drive change. Accountability to board level staff. Initiative delivering multimillion dollar annual savings and improving speed to market.Prominent in the external scientific and business community including Member of the Expert Working Groups for revision of ICH S1 (Rodent Carcinogenicity Studies for Human Pharmaceuticals) and ICH S9 (Nonclinical Evaluation for Anticancer Pharmaceuticals) Question & Answer; Member of the Preclinical Development Committee of EFPIA (European Federation of Pharmaceutical Industries and Associations); Member Board of Directors UCLA Anderson Business School
2006 - 2016
~10 yrs
Principal Pathologist
I was a toxicologic pathologist, toxicology project representative, and managed a pathology special techniques lab including validation of human tissue biomarkers.
2002 - 2006
~4 yrs
Director
I lead the Nonclinical Evaluation of Novel Therapeutics for the neurology Centre of Excellence for Drug Discovery
1999 - 2002
~3 yrs
4 education records
Ian Pyrah education
Emba, Business Administration And Management, General
Ucla Anderson School Of Management
Emba, Business Administration And Management, General
National University Of Singapore
Doctor Of Philosophy (Phd), Veterinary Pathology And Pathobiology
The University Of Edinburgh
Bvm&S, Veterinary Science
The University Of Edinburgh
FAQ
Frequently asked questions about Ian Pyrah
Quick answers generated from the profile data available on this page.
What company does Ian Pyrah work for?
Ian Pyrah works for Kailera Therapeutics.
What is Ian Pyrah's role at Kailera Therapeutics?
Ian Pyrah is listed as SVP Non-Clinical Development at Kailera Therapeutics.
What is Ian Pyrah's email address?
AeroLeads has found 1 work email signal at @seagen.com for Ian Pyrah at Kailera Therapeutics.
What is Ian Pyrah's phone number?
AeroLeads has found 1 phone signal(s) with area code 805 for Ian Pyrah at Kailera Therapeutics.
Where is Ian Pyrah based?
Ian Pyrah is based in Greater Seattle Area, United States while working with Kailera Therapeutics.
What companies has Ian Pyrah worked for?
Ian Pyrah has worked for Kailera Therapeutics, Immunome, Inc., Stealth Biotech Startup, Seattle Genetics, and Amgen.
How can I contact Ian Pyrah?
You can use AeroLeads to view verified contact signals for Ian Pyrah at Kailera Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Ian Pyrah attend?
Ian Pyrah holds Emba, Business Administration And Management, General from Ucla Anderson School Of Management.
What skills is Ian Pyrah known for?
Ian Pyrah is listed with skills including Drug Discovery, Toxicology, Pathology, Drug Development, Biomarkers, Regulatory Affairs, Validation, and Cro.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial